The Latest Breaking News from ZSAN

Zosano Pharma: Q1 Earnings Insights

Zosano Pharma (NASDAQ:ZSAN) reported its Q1 earnings results on Friday, May 13, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Zosano Pharma reported in-line EPS of $-1.75 versus an estimate of $-1.75.

Benzinga · May 13, 2022

Zosano Pharma's Return On Capital Employed Insights

According to data from Benzinga Pro, during Q4, Zosano Pharma's (NASDAQ:ZSAN) reported sales totaled $87.00 thousand. Despite a 19.58% increase in earnings, the company posted a loss of $6.97 million.

Benzinga · May 9, 2022

Zosano Pharma Announces Additional Workforce Layoff

The FDA had granted Zosano Pharma Corporation (NASDAQ: ZSAN) a twelve-month extension to April 20, 2023, to resubmit its M207 marketing application.

Benzinga · May 2, 2022